Literature DB >> 8586289

Percutaneous endoscopic gastrostomy in geriatric patients: attitudes of health care professionals.

M Hasan1, R J Meara, B K Bhowmick, K Woodhouse.   

Abstract

This study investigated, by questionnaire, the attitudes of geriatricians, speech therapists, dieticians, and nurses towards feeding by percutaneous endoscopic gastrostomy (PEG). The final response rate from a total of 199 questionnaires sent to this group was 75%. According to 95 (64%) of the respondents, the decision to use PEG feeding was reached by a multidisciplinary team approach and commonly involved carers as well as the patients. The quality of life was the single most important factor influencing this decision. PEG feeding was felt to be indicated in non-dysphagia-related malnutrition by 98 (66%) and in dementia with rejection of oral feeding by 69 (47%) of the respondents. It was felt by 39 (55%) of the nurses and by 32 (42%) of the other professionals that patients with dementia in long-term care who are established on nasogastric feeding should be converted to PEG feeding. This raises several ethical and resource issues.

Entities:  

Mesh:

Year:  1995        PMID: 8586289     DOI: 10.1159/000213704

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  3 in total

Review 1.  [Tube-feeding in advanced dementia. An evidence-based ethical analysis].

Authors:  M Synofzik
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

2.  Long-term nasogastric tube feeding in elderly stroke patients--an assessment of nutritional adequacy and attitudes to gastrostomy feeding in Asians.

Authors:  F Zaherah Mohamed Shah; H-S Suraiya; P J-H Poi; K S Tan; P S M Lai; K Ramakrishnan; S Mahadeva
Journal:  J Nutr Health Aging       Date:  2012-08       Impact factor: 4.075

Review 3.  How are treatment decisions made about artificial nutrition for individuals at risk of lacking capacity? A systematic literature review.

Authors:  Gemma Clarke; Katy Harrison; Anthony Holland; Isla Kuhn; Stephen Barclay
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.